Thrombophilic polymorphisms - Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations - And preterm birth

Wiener Klinische Wochenschrift

Volumn 116, Issue 17-18, 2004, Pages 622-626

  Resch, Bernhard ^a   Gallistl, Siegfried ^a   Kutschera, Jörg ^a   Mannhalter, Christine ^b   Muntean, Wolfgang ^a   Mueller, Wilhelm D ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Factor V Leiden; Methylenetetrahydrofolate reductase C677T mutation; Preterm birth; Prothrombin G20210A variant

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FETUS WASTAGE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PREMATURITY; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GESTATIONAL AGE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT, NEWBORN; MATERNAL AGE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; PREMATURE BIRTH; PROTHROMBIN; THROMBOPHILIA;

EID: 5344221551     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-004-0223-9     Document Type: Article

References (23)

1. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67
2. Rosendaal FR, Koster T, Vandenbrouke JP, Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85: 1504-1508
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gen is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood 88: 3698-3703
4. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al (1995) 5 A candidate genetic risk factor for vascular disease: a common mutation in methlenetetrahdrofolate reductase. Nat Genet 10: 111-113
5. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 342: 374-380
6. Pabinger I, Grafenhofer H (2003) Pregnancy-associated thrombosis. Wien Klin Wochenschr 115: 482-484
7. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntop E, Conard J, et al (1996) Increased fetal loss in women with heritable thrombophilia. Lancet 348: 913-916
8. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Capucci G, Vecchione G, et al (1997) Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 77: 822-824
9. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N (1999) Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 82: 6-9
10. Stoll BJ, Kliegman RM (2000) The fetus and the neonatal infant. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. Saunders, Philadelphia London Toronto Montreal Sydney Tokyo, pp 477
11. Watzke HH (2003) Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors. Wien Klin Wochenschr 115: 475-481
12. Kupfermine MJ, Eldor A, Steinmann N, Many A, Bar-Am A, Jaffa A, et al (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340: 9-13
13. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, et al (1997) 7 Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 199: 551-554
14. Glueck CJ, Phillips H, Cameron D, Wang P, Fontain RN, Moore SK, et al (2000) The 4G/5G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 49: 845-852
15. Von Kries R, Junker R, Oberle D, Kosch A, Nowak-Göttl U (2001) Foetal growth restriction in children with prothrombotic risk factors. Thromb Haemost 86: 1012-1016
16. Infante-Rivard C, Rivard GE, Yotov WV, Genin E, Guiguet M, Weinberg C, et al (2002) Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 347: 19-25
17. Roberts D, Schwarz RS (2002) Clotting and hemorrhage in the placenta - a delicate balance. N Engl J Med 347: 57-59
18. Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupfermine MJ (2001) Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 98: 1041-1044
19. Sikkema JM, Franx A, Bruinse HW, van der Wijk NG, de Valk HW, Nikkels PG (2002) Placental pathology in early onset preeclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 23: 337-342
20. Mousa HA, Alfirevicl Z (2000) Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 15: 1830-1833
21. Lockwood CJ (2002) Predicting premature delivery - no easy task. N Engl J Med 347: 282-284
22. 506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. Nephrol Dial Transplant 11: 668-672
23. Göpel W, Kim D, Gortner L (1999) Prothrombotic mutations as a risk factor for preterm birth. Lancet 353: 1411-1412